Ischemia
Disturbances of cerebral blood flow (CBF) following severe TBI has been the focus of
considerable attention and has led to the assumption that ischemia was a major cause of secondary brain injury. This concept should be viewed in the context of pathologic studies performed in the 1970s; ischemic neuronal damage was a common finding in the brains of patients who died following TBI (
27,
28). However, the population studied was skewed because only patients whose initial injury was severe enough to be fatal were included. In addition, the pathologic findings could have resulted from systemic hypotension, hypoxia, or aggressive hyperventilation. Some regions of ischemia were attributed to vasospasm, a phenomenon that has been difficult to corroborate and is not reflected in the more global reduction in flow summarized below. Thus, the frequency of ischemia in patients who survive with present-day treatment, the time period during which it occurs, its contribution to secondary injury, and its impact on outcome are not known.
Physiologic studies performed 20 or more years ago found hemispheric CBF to be moderately reduced in most patients 1 to 2 days after TBI (
29,
30), whereas others reported hyperemic hemispheric flow (normal or elevated CBF in comatose patients) in over 50% of patients studied within 96 hours of trauma. More recent studies performed during the first few hours after injury found hemispheric CBF to be low in most cases (
24,
31). In studies performed very early after injury (average of 3.1 hours), Bouma and coworkers (
32) reported global or regional CBF of <18 mL/100 g per minute (considered to be a critical level for ischemic damage) in one third of patients. Subsequent studies that included patients with mass lesions (
33) also found regional CBF below this threshold in almost 30% of patients studied within 4 hours, and in 20% of patients studied 4 to 8 hours after injury. Furthermore, low blood flow was associated with poor outcome (
34).
Several studies of global cerebral metabolic rate for oxygen (CMRO
2) using simultaneous sampling of arterial and jugular venous blood have reported low global CMRO
2 (
29,
34,
35 and
36). CMRO
2 also was found to correlate with the level of consciousness (
35,
36) and outcome (
23).
The oxygen/lactic acid index, derived from arterial and jugular venous blood, also has been used to define cerebral ischemia (
37,
38). Some caution needs to be exercised in the interpretation of lactate levels because increased brain lactate production can occur in the presence of adequate CBF and oxygen delivery (
39,
40). In addition, increased levels of lactate also may result from the accumulation of white blood cells following TBI (
41,
42 and
43), or reduced clearance of lactate caused by low CBF.
The arteriovenous difference in oxygen content (a-vDO
2) has been used to assess for global ischemia following TBI. Normal values for a-vDO
2 range from approximately 4.5 vol% to 9 vol% (
44,
45,
46 and
47). When ischemia was defined as a-vDO
2 <10 vol% Obrist found evidence of ischemia in only one of 75 TBI patients (
35).
Recently, a number of studies have suggested an alternative explanation for reduced CBF following TBI. There is a growing body of evidence that following TBI, subarachnoid hemorrhage (
48), and intracerebral hemorrhage (
49), metabolic suppression may be the primary event and this is followed by a passive fall in CBF. Using a number of experimental models of TBI, investigators have found impaired mitochondrial function (
4,
50), which results in diminished ATP production. Preliminary positron emission tomography (PET) studies in TBI patients have suggested that there may be a compensatory rise in glucose use (
51). Recently, biopsies from a small series of patients with severe TBI also demonstrated impaired mitochondrial function, and some have proposed that mitochondrial function may be used as a surrogate efficacy measure for preclinical studies of head injury (
50).
If it is confirmed that mitochondrial function is impaired following TBI, it will fundamentally affect how TBI patients are treated. Current approaches to treatment focus on improving CBF and delivery of energy substrates (oxygen and glucose). If the limiting factor in ATP synthesis is the inability of the
mitochondria to use oxygen, then improving delivery may not have much impact. Instead treatment strategies should be directed toward improving mitochondrial function.
The question of ischemia remains unresolved at present. If present it is most likely limited to the first few hours following injury. During that period maintaining adequate blood pressure is essential (see the following) and management of elevated ICP is appropriate. Whether continuing to aggressively treat ICP and CPP in the subsequent days is useful is uncertain; such efforts should be integrated with the patient’s overall clinical status.